Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers


1. Unii-nzw2bow35n
2. 929046-33-3
3. Nt-814
4. Elinzanetant [inn]
5. Elinzanetant [usan]
6. Nzw2bow35n
7. Bay3427080
8. Bay-3427080
9. 2-(3,5-bis(trifluoromethyl)phenyl)-n-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-7-(hydroxymethyl)hexahydropyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,2-dimethylpropanamide
10. 2-[3,5-bis(trifluoromethyl)phenyl]-n-{4-(4-fluoro-2-methylphenyl)-6-[(7s,9as)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1h)-yl]-3-pyridinyl}-n,2-dimethylpropanamide
11. Elinzanetant [who-dd]
12. Schembl303180
13. Chembl4802157
14. Dtxsid101337049
15. Ex-a6225
16. Who 10952
17. Hy-109171
18. Cs-0116361
19. 2-[3,5-bis(trifluoromethyl)phenyl]-n-{4-(4-fluoro-2-methylphenyl)-6-[(7s,9as)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1h)-yl]pyridin-3-yl}-n,2-dimethylpropanamide
20. Benzamide, 3-(5-methyl-2-tbenzeneacetamide, N-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-hexahydro-7-(hydroxymethyl)pyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,.alpha.,.alpha.-trimethyl-3,5-bis(trifluoromethyl)-
21. Benzamide, 3-(5-methyl-2-tbenzeneacetamide, N-(4-(4-fluoro-2-methylphenyl)-6-((7s,9as)-hexahydro-7-(hydroxymethyl)pyrazino(2,1-c)(1,4)oxazin-8(1h)-yl)-3-pyridinyl)-n,alpha,alpha-trimethyl-3,5-bis(trifluoromethyl)-
22. N-[6-[(7s,9as)-7-(hydroxymethyl)-3,4,6,7,9,9a-hexahydro-1h-pyrazino[2,1-c][1,4]oxazin-8-yl]-4-(4-fluoro-2-methylphenyl)pyridin-3-yl]-2-[3,5-bis(trifluoromethyl)phenyl]-n,2-dimethylpropanamide
| Molecular Weight | 668.6 g/mol |
|---|---|
| Molecular Formula | C33H35F7N4O3 |
| XLogP3 | 5.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 6 |
| Exact Mass | 668.25973813 g/mol |
| Monoisotopic Mass | 668.25973813 g/mol |
| Topological Polar Surface Area | 69.1 Ų |
| Heavy Atom Count | 47 |
| Formal Charge | 0 |
| Complexity | 1060 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
23
PharmaCompass offers a list of Elinzanetant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Elinzanetant manufacturer or Elinzanetant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Elinzanetant manufacturer or Elinzanetant supplier.
PharmaCompass also assists you with knowing the Elinzanetant API Price utilized in the formulation of products. Elinzanetant API Price is not always fixed or binding as the Elinzanetant Price is obtained through a variety of data sources. The Elinzanetant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Elinzanetant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elinzanetant, including repackagers and relabelers. The FDA regulates Elinzanetant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elinzanetant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Elinzanetant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Elinzanetant supplier is an individual or a company that provides Elinzanetant active pharmaceutical ingredient (API) or Elinzanetant finished formulations upon request. The Elinzanetant suppliers may include Elinzanetant API manufacturers, exporters, distributors and traders.
click here to find a list of Elinzanetant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Elinzanetant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elinzanetant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elinzanetant GMP manufacturer or Elinzanetant GMP API supplier for your needs.
A Elinzanetant CoA (Certificate of Analysis) is a formal document that attests to Elinzanetant's compliance with Elinzanetant specifications and serves as a tool for batch-level quality control.
Elinzanetant CoA mostly includes findings from lab analyses of a specific batch. For each Elinzanetant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elinzanetant may be tested according to a variety of international standards, such as European Pharmacopoeia (Elinzanetant EP), Elinzanetant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elinzanetant USP).